Compare NKTR & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NKTR | CLMT |
|---|---|---|
| Founded | 1990 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | 1996 | 2024 |
| Metric | NKTR | CLMT |
|---|---|---|
| Price | $71.50 | $43.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $146.67 | $28.65 |
| AVG Volume (30 Days) | 833.2K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 85.39 |
| EPS | ★ N/A | N/A |
| Revenue | $307,711,000.00 | ★ $4,137,100,000.00 |
| Revenue This Year | N/A | $3.94 |
| Revenue Next Year | N/A | $1.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 86.00 | N/A |
| 52 Week Low | $21.02 | $12.94 |
| 52 Week High | $109.00 | $45.20 |
| Indicator | NKTR | CLMT |
|---|---|---|
| Relative Strength Index (RSI) | 54.99 | 66.26 |
| Support Level | $64.28 | $30.74 |
| Resistance Level | $76.78 | N/A |
| Average True Range (ATR) | 3.57 | 1.64 |
| MACD | 0.17 | -0.09 |
| Stochastic Oscillator | 66.12 | 56.72 |
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.